简介:摘要在法医医学鉴定过程中经常会遇到基因丢失的情况,导致亲子代在基因鉴定过程中出现不符合遗传规律的情况,在一定程度上增加了被错误排除的风险。由于等位基因的缺失在一定程度上和模板的DNA多态性、碱基的插入或缺失有关,因此正确识别和分析等位基因对鉴定结果会产生直接的影响。基于此,本文作者结合自身实践就TH01基因座丢失的相关问题进行相关阐述。
简介: 【摘要】目的:分析卡马西平联合地西泮对脑梗并发癫痫治疗效果、 CL-90评分及 MBI评分的影响。方法:本文研究对象为脑梗并发癫痫患者,研究总例数 200例,收取时间在 2018年 1月 5日 -2020年 3月 10日之间,总例数采取抽签分组方式分为两组,观察组 100例(实施卡马西平联合地西泮治疗)、对照组 100例(实施常规治疗),将两组的 CL-90评分、 MBI评分、总有效率进行对比。结果:观察组脑梗并发癫痫患者 CL-90评分( 61.25±6.11)分、 MBI评分( 62.12±9.11)分低于对照组患者( P<0.05) ;观察组脑梗并发癫痫患者总有效率 90.00%(显效患者 80例、有效患者 10例、无效患者 10例)高于对照组患者( P<0.05)。结论:通过对脑梗并发癫痫患者实施卡马西平联合地西泮治疗后,取得显著效果,能改善患者 CL-90评分及 MBI评分,提高患者治疗效果。 【关键词】卡马西平 ;地西泮 ;脑梗并发癫痫 ;治疗效果 ;CL-90评分 ;MBI评分 [Abstract] Objective: to analyze the effect of carbamazepine combined with diazepam on cerebral infarction complicated with epilepsy, cl-90 score and MBI score. Methods: 200 cases of cerebral infarction complicated with epilepsy were selected in this study. The total number of cases was collected from January 5, 2018 to March 10, 2020. The total number of cases was divided into two groups by drawing lots. The observation group had 100 cases (implemented carbamazepine combined with diazepam treatment) and the control group (100 cases received conventional treatment). The cl-90 score, MBI score and total effective rate of the two groups were compared Than. Results: the cl-90 score (61.25 ± 6.11) and MBI score (62.12 ± 9.11) of the observation group were lower than those of the control group (P < 0.05); the total effective rate of the observation group was 90.00% (80 cases of markedly effective patients, 10 cases of effective patients, 10 cases of ineffective patients) was higher than that of the control group (P < 0.05). Conclusion: after the implementation of carbamazepine combined with diazepam in the treatment of cerebral infarction complicated with epilepsy, significant effect has been achieved, which can improve the cl-90 score and MBI score, and improve the treatment effect of patients.